National Health Partners, Inc. (OTC:NHPR) closed Friday session with no change in the share price and a mediocre trading volume. Though, that lack of significant trading activity and the low value for the stock might be a good starting point for the new promotions for NHPR that started over the weekend. 
Our newsletters database shows that the group of promoters that recommended NHPR in the past two months is back again. We have collected several new promotional e-mails in the last days which could make up for a new hot trading session for the stock. Compensation stays the same: the promoters state again in the disclaimer to have received 3 million restricted shares of National Health Partners directly from the company, as well as 3 million free trading shares of NHPR from a third party.
The advertising contract is for six months, which means that probably more promotions are expected to come. If the promo rush for the shares from the end of May could repeat itself, is another question though. On Friday, NHPR closed the market at $0.0125 for a share with no change in the price from the previous close. Only 40,000 shares were traded, as the intraday chart shows, mostly in one transaction.
According to the company’s latest 10-Q, the company sells healthcare membership programs, though that business has not been that profitable so far. As of end-March 2011 NHPR had around $4,000 in cash and was unable to cover its current debts, while the net loss for the first three months of the year was almost $159,000. In accordance with its weak financial position, NHPR paid with stocks not only for the disclosed promotions, but also for certain other management consulting and marketing services.
During the first four months of 2011, NHPR issued 19.8 million common shares to consultants, while two capital raising transaction this year have additionally diluted the shareholders. In January, the company sold 8 million warrants to purchase 8 million shares of common stock at an exercise price of $0.005 per share. Total proceeds from the private placement were $800, while shortly after that the warrants were exercise for cash consideration of $40,000.
Another 4 million warrants to purchase 4 million common shares at an exercise price of $0.01 or $0.015 were issued in January and in February. It looks like these warrants are still outstanding.
